相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dual cancer stem cell manipulation to enhance phototherapy against tumor progression and metastasis
Qi Shang et al.
JOURNAL OF CONTROLLED RELEASE (2021)
A two-pronged photodynamic nanodrug to prevent metastasis of basal-like breast cancer
Jing Zhang et al.
CHEMICAL COMMUNICATIONS (2021)
The curious phenomenon of dual-positive circulating cells: Longtime overlooked tumor cells
Carolina Reduzzi et al.
SEMINARS IN CANCER BIOLOGY (2020)
Circulating Tumor Cells are an Independent Predictor of Shorter Survival in Patients Undergoing Resection for Pancreatic and Periampullary Adenocarcinoma
Harald Hugenschmidt et al.
ANNALS OF SURGERY (2020)
Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer
Louis Buscail et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Updated risk factors to inform early pancreatic cancer screening and identify high risk patients
Daniel R. Principe et al.
CANCER LETTERS (2020)
Tumor-Cell-Macrophage Fusion Cells as Liquid Biomarkers and Tumor Enhancers in Cancer
Yariswamy Manjunath et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Expansion of Circulating Tumor Cells from Patients with Locally Advanced Pancreatic Cancer Enable Patient Derived Xenografts and Functional Studies for Personalized Medicine
Lianette Rivera-Baez et al.
CANCERS (2020)
Analysis of circulating breast cancer cell heterogeneity and interactions with peripheral blood mononuclear cells
Heather M. Brechbuhl et al.
MOLECULAR CARCINOGENESIS (2020)
Simultaneous Single Cell Gene Expression and EGFR Mutation Analysis of Circulating Tumor Cells Reveals Distinct Phenotypes in NSCLC
Sarah Owen et al.
ADVANCED BIOSYSTEMS (2020)
OPENchip: an on-chip in situ molecular profiling platform for gene expression analysis and oncogenic mutation detection in single circulating tumour cells
Amos C. Lee et al.
LAB ON A CHIP (2020)
Tumour-reprogrammed stromal BCAT1 fuels branched-chain ketoacid dependency in stromal-rich PDAC tumours
Ziwen Zhu et al.
NATURE METABOLISM (2020)
LAMB3 mediates apoptotic, proliferative, invasive, and metastatic behaviors in pancreatic cancer by regulating the PI3K/Akt signaling pathway
Hong Zhang et al.
CELL DEATH & DISEASE (2019)
An Integrative Data Mining and Omics-Based Translational Model for the Identification and Validation of Oncogenic Biomarkers of Pancreatic Cancer
Nguyen Phuoc Long et al.
CANCERS (2019)
Circulating Tumor Cells in Pancreatic Cancer: Current Perspectives
Verena Martini et al.
CANCERS (2019)
Single molecule characterization of individual extracellular vesicles from pancreatic cancer
Kathleen M. Lennon et al.
JOURNAL OF EXTRACELLULAR VESICLES (2019)
Detection of CTC Clusters and a Dedifferentiated RNA-Expression Survival Signature in Prostate Cancer
Molly Kozminsky et al.
ADVANCED SCIENCE (2019)
Higher CXCL16 exodomain is associated with aggressive ovarian cancer and promotes the disease by CXCR6 activation and MMP modulation
Hina Mir et al.
SCIENTIFIC REPORTS (2019)
Circulating Hybrid Cells Join the Fray of Circulating Cellular Biomarkers
Thomas L. Sutton et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2019)
KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer
Andrew M. Waters et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Identification of Prognostic Biomarkers by Combined mRNA and miRNA Expression Microarray Analysis in Pancreatic Cancer
Bin Liu et al.
TRANSLATIONAL ONCOLOGY (2018)
Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival
Charles E. Gast et al.
SCIENCE ADVANCES (2018)
Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations
Birte Kulemann et al.
SCIENTIFIC REPORTS (2017)
High-Throughput Microfluidic Labyrinth for the Label-free Isolation of Circulating Tumor Cells
Eric Lin et al.
CELL SYSTEMS (2017)
Regulatory B cells induced by pancreatic cancer cell-derived interleukin-18 promote immune tolerance via the PD-1/PD-L1 pathway
Yan Zhao et al.
Oncotarget (2017)
Stealth dissemination of macrophage-tumor cell fusions cultured from blood of patients with pancreatic ductal adenocarcinoma
Gary A. Clawson et al.
PLOS ONE (2017)
KRAS mutations in pancreatic circulating tumor cells: a pilot study
Birte Kulemann et al.
TUMOR BIOLOGY (2016)
Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma
Katherine E. Poruk et al.
ANNALS OF SURGERY (2016)
Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities
Barbara Bournet et al.
EUROPEAN JOURNAL OF CANCER (2016)
Opportunities and Challenges for Pancreatic Circulating Tumor Cells
Sunitha Nagrath et al.
GASTROENTEROLOGY (2016)
Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids
Taisuke Imamura et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Combined preoperative concentrations of CEA, CA 19-9, and 72-4 for predicting outcomes in patients with gastric cancer after curative resection
Xuechao Liu et al.
ONCOTARGET (2016)
The role of S100 proteins and their receptor RAGE in pancreatic cancer
Estelle Leclerc et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Circulating tumor cells (Ctc) and kras mutant circulating free Dna (cfdna) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer
Julie Earl et al.
BMC CANCER (2015)
MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells
Patricia Sancho et al.
CELL METABOLISM (2015)
EMT, CTCs and CSCs in tumor relapse and drug-resistance
Abhisek Mitra et al.
ONCOTARGET (2015)
Single-Cell RNA Sequencing Identifies Extracellular Matrix Gene Expression by Pancreatic Circulating Tumor Cells
David T. Ting et al.
CELL REPORTS (2014)
VEGF-A/VEGFR-2 Signaling Plays an Important Role for the Motility of Pancreas Cancer Cells
Yosuke Doi et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
CA 19-9 in pancreatic cancer: retrospective evaluation of patients with suspicion of pancreatic cancer
Victor Molina et al.
TUMOR BIOLOGY (2012)
Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells
Sabine Kasimir-Bauer et al.
BREAST CANCER RESEARCH (2012)
Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients
Cristina Raimondi et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Impact of KRAS Mutations on Clinical Outcomes in Pancreatic Cancer Patients Treated with First-line Gemcitabine-Based Chemotherapy
Seung Tae Kim et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Prognostic Significance of Tumorigenic Cells With Mesenchymal Features in Pancreatic Adenocarcinoma
Zeshaan A. Rasheed et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Gene Expression Levels as Predictive Markers of Outcome in Pancreatic Cancer after Gemcitabine-Based Adjuvant Chemotherapy
Hayato Fujita et al.
NEOPLASIA (2010)
Testing significance relative to a fold-change threshold is a TREAT
Davis J. McCarthy et al.
BIOINFORMATICS (2009)
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2008)
Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis
Jing Yang et al.
DEVELOPMENTAL CELL (2008)
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer
Steven J. Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma
Moritz N. Wente et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2008)
ADAMs in cancer cell proliferation and progression
Satsuki Mochizuki et al.
CANCER SCIENCE (2007)
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival
Daniel F. Hayes et al.
CLINICAL CANCER RESEARCH (2006)
S100P promotes pancreatic cancer growth, survival, and invasion
T Arumugam et al.
CLINICAL CANCER RESEARCH (2005)
ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma
R Grützmann et al.
BRITISH JOURNAL OF CANCER (2004)
分享论文
